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1 Introduction 
1.1 Nutrition during pregnancy & the role of folate and docosahexaenoic 
acid 
In Europe, women can easily meet their enhanced energy and protein needs during 
pregnancy to support fetal growth and expansion of maternal tissues. However, the 
increase in requirements of some micronutrients and of n-3 fatty acids is far higher than 
the enhancement in energy requirement. The recommended increase of energy intake 
during pregnancy is 17-22 %, whereas the reference intakes for some minerals and 
vitamins increase much more. For example folate requirements increase by approximately 
50 % and requirements for the n-3 FA DHA increase by approximately 40 % (Table 1) (1). 
 
Folic acid is essential for synthesis, repair, and function of DNA and the cell division (2;3). 
Research during the last years has established that low or inadequate folate status may 
contribute to congenital malformations and the development of chronic disease in later 
life. Neural tube defects (NTDs) are common major congenital anomalies, with folic acid 
as the primary known environment factor. A poor folate status during early pregnancy is 
associated with increased rates of neural tube defects (4-6). A similar protective effect of 
folic acid has been also postulated for non-neural birth defects, like congenital heart 
defects and oral clefts. It is widely accepted that a periconceptional folic acid 
supplementation decreases the occurrence of neural tube defects (5) and additional folate 
intake may also reduce pregnancy complications like pre-eclampsia and adverse neonatal 
outcomes. Mahomed showed in his metaanalysis that routine folate supplementation 
during pregnancy resulted in a reduction of the incidence of low serum as well as red cell 
folate levels (7). Pregnant women are recommended to consume synthetic folic acid from 
fortified foods, supplements or both, in addition to consuming folate from a varied diet. But 
in reality these recommendations are often not implemented. The PEGASUS study shows 
that less than 10 % of more than 900 women took folic acid during the critical period 
before conception and the first time of pregnancy. Furthermore, researches showed that 
mainly mothers who were not taking folic acid were less educated, from lower socio-
economic groups and were not actively trying to fall pregnant at the time they became 
pregnant (8;9). 
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There for, campaigns were established during the last years to improve periconceptional 
folic acid use in many countries (10). As a consequence, in the Netherlands the use of 
folate supplements increased from 4.8 % to 21 % within 1 year (11). 
A further nutrient with particular relevance for perinatal development is docosahexaenoic 
acid (DHA), a α n-3 long-chain polyunsaturated fatty acid (n-3 LCPUFA) (12). DHA is an 
essential component of all cell membranes in the brain and other tissues, with relevance 
for fetal neurological development (13-17). Several controlled studies found that DHA 
availability during gestation is associated with improved cognitive and visual development 
as well as reduced risk of early preterm birth (18-20). Perinatal n-3 supply is largely 
dependent on maternal dietary intake (21), because the fetal enzymatic system seems to 
be unable to supply sufficient amounts to meet the high perinatal needs (Figure 2) . 
Mothers may also functionally benefit from LCPUFA supplementation themselves, 
because a higher DHA status at delivery (22) and a better improvement of the maternal 
DHA status after delivery (23) are associated with less depressive symptoms in the post 
partum period. An average dietary DHA intake of at least 200 mg per day has been 
recommended for pregnant and breastfeeding women, which can be realized by 
consuming one to two portions of fatty fish per week (24). Because of the existing heavy 
metal contamination (methylmercury), pregnant women should select their dietary fish 
from a wide range of species (25). In the coming years, alternative strategies, such as n-3 
fatty acid supplements and food enrichment will get more and more important to satisfy 
the demand and to solve the problems of contamination and overfishing. 
The positive effects summarized above indicate that it may be beneficial to increase the 
intake of n-3 FA during pregnancy to optimize maternal and fetal status. However, 
LCPUFA are susceptible to peroxidation and even during normal pregnancy, there is an 
increase in lipid peroxidation products and oxidative stress (26). An excessive dietary 
intake of LCPUFA may enhance lipid peroxidation and reduce antioxidative capacity (27). 
 
 
1.2 Oxidative Balance and Redoxsystem 
Pregnancy is a physiological state associated with increased energy demands and 
elevated oxygen requirements. Several studies have indicated that women with normal 
pregnancies showed increased oxidative stress and higher lipid peroxidation products 
compared with non-pregnant women (26). At the beginning of pregnancy there is an 
increase in body fat accumulation, associated with increased lipogenesis. During 
advanced pregnancy a dearangement of the oxidative balance could lead to inflammatory 
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changes, thus triggering complications, such as preeclampsia, growth retardation or 
premature labour (28). A major source of oxidative stress during pregnancy is the 
placenta, which is rich in PUFA and thus a source of lipid peroxides for the maternal 
metabolism. 
During the last few years, lipid peroxidation and its products (Figure 3) gained more and 
more attention in respect to pregnancy outcome. The multisystem disorder preeclampsia 
is associated with an imbalance between antioxidants and oxidants, which could lead to 
premature delivery and intrauterine fetal growth retardation. Kim et al found a relation 
between oxidative stress biomarkers (MDA and 8-Hydroxydeoxyguanosine) and reduced 
neonatal birth weight (29). However, the human metabolism has evolved a complex 
system to minimize the harmful effects of ROS. During pregnancy, not only oxidative 
stress increases, there is also an adapted increase of antioxidants and antioxidative 
enzymes (30;31). If there is no adaptation, miscarriage might be the consequence (30). 
 
 
Figure 1 Course of interventions and analyses. 
 
 
There are many different analyses to determine the extent of lipid peroxidation belonging 
to 2 main categories, the measurement of oxidative damage and / or the measurement of 
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antioxidative protection. We investigated longitudinal changes in the maternal redox status 
of plasma and the effect of fish oil and folate supplementation, using thiobarbituric acid 
reactive substances (TBARS) as marker of lipid peroxidation, and different non enzymatic 
antioxidants, because one measured lipid peroxidation marker may not provide a definite 
answer (Figure 1; Figure 4 & Figure 5).  
 
Given the relevance of DHA and folate supply during pregnancy, we assessed additionally 
the dietary intake of these nutrients to obtain data on current intakes in the 3 European 
samples. Such information is the basis to identify risk groups for inadequate supply as 
well as to perform calculations to assess the progression by enriched food or 
supplements. The study population was drawn from participants of the NUHEAL Study 
(Nutraceuticals for a Healthier Life), a prospective randomized intervention study which 
compared the effects of a dietary supplementation with fish oil and/or 5-methyl-tetra-
hydro-folate (MTHF) during the second half of gestation in mothers from 3 different 
European populations (32). The cohorts were taken from 3 European countries selected 
on the basis of their location and distance to the sea, which should be reflected in a 
different fish intake. 
 
According to the conceptual framework in Figure 1, the research question of this thesis 
was subdivided into the analysis of the nutrition situation and the analysis of the plasma 
redox parameter, which leads to the following research questions: 
 
(1) Characterisation of the dietary supply of folate and DHA in the 3 study populations 
compared to the recommendations.  
 
(2) What are the effects of the supplementation on the maternal plasma redox status 
during the time course of the pregnancy? 
 
(3) Does the redox status, and the response to supplementation, differ during the time 
course of the preganancy? 
 





The first research question about the dietary intakes of folate and DHA is addressed in an 
article entitled “Dietary Intake of Natural Sources of Docosahexaenoic Acid and Folate in 
Pregnant Women of Three European Cohorts”. A food frequency questionnaire (FFQ) was 
created with special focus on the sources of folate and DHA. This FFQ was completed 
twice during the second half of pregnancy by the NUHEAL participants and the resulting 
data are used for different statistical analyses. 
The second research question is addressed in an article entitled “Influence of fish oil or 
folate supplementation on the time course of plasma redox markers during pregnancy”, 
which is based on survey data collected at week 20 (±1 week), week 30 (±1 week) and at 
the time of delivery. The research includes parameter of the plasma redox status, which 
were analysed regarding group differences and longitudinal changes as well. 
The third research question is addressed in an article entitled “Effect of docosahexaenoic 
acid and eicosapentaenoic acid supplementation on oxidative stress levels during 
pregnancy”. Here, the urinary excretion of 8-hydroxy-2’-deoxyguanosine (8-OHdG) and 
malondialdehyde (MDA) was measured in a sub-group of the NUHEAL population. 
 
In a final chapter of this cumulative dissertation, the main findings of the three articles are 




1.3 Authors contributions 
Within the NUHEAL-project I was responsible for performing the following analysis, for 
data interpretation and for preparing of the manuscripts. 
 
• laboratory analyses of uric acid, thiol groups, TEAC, TBARS 
• analysis of the food frequency questionnaires 
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4 Summary (English) 
This cumulative dissertation was prepared within the NUHEAL-trial (NUHEAL = 
Nutraceutical for a Healthier Life“, EU FP5, CLK1-CT-1999-00888), a prospective 
randomised interventional trial in pregnant women, which evaluates the beneficial roles 
and interactions of long-chained n-3 polyunsaturated fatty acids (n- 3 LC PUFA) and 5-
methyl-tetra-hydro-folate (5-MTHF) in cardiovascular health and infant development. 
Samples were available from women participating in Germany, Spain and Hungary. The 
participants were randomised into 4 different supplementation groups receiving milk 
based supplements (Blemil plus, Laboratorios Ordesa, Barcelona, Spain) containing 
modified fish oil (500 mg docosahexaenoic acid, 150 mg eicosapentaenoic acid daily) 
and/or 400 µg 5-methyl-tetrahydrofolate or placebo. All supplements provided 270 mg 
vitamin C and 3 mg α-tocopherol daily. The importance of an optimised supply of long 
chain polyunsaturated fatty acids (LCPUFA) during pregnancy for fetal growth and 
development is widely accepted. A fish oil supplementation can enhance DHA blood 
levels during pregnancy. However, LCPUFA are susceptible to peroxidation and require 
adequate antioxidative protection.  
 
This dissertation investigates in three articles the effects of a supplementation with fish oil 
and / or folate on redox-related biomarkers during pregnancy as well as the supply with 
dietary folate and DHA in pregnant women to identify possible inadequateness. The article 
“Influence of fish oil or folate supplementation on the time course of plasma redox markers 
during pregnancy” compares the effects of a dietary supplementation with fish-oil and / or 
5-methyl-tetrahydrofolate (5-MTHF) from week 20 of gestation until delivery on plasma 
redox-status. As redox status can not be adequately assessed from a single analytical 
parameter, a set of marker substances was analyzed; α-tocopherol, free thiol groups, uric 
acid and total antioxidant capacity (TEAC) as well as thiobarbituric acid reactive 
substances (TBARS) in blood samples collected at gestational weeks 20, 30 and at the 
time of delivery. Studied antioxidants showed no significant differences between the 4 
supplementation groups. At week 30 plasma TBARS levels were found to be significantly 
higher in the fish oil group than in the folate and control group. Until the end of pregnancy 
TBARS increased intensely in all groups without any significant group differences at 
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delivery. Concentrations of retinol and free thiol groups decreased during pregnancy, 
whereas uric acid increased and ß-carotene as well as the antioxidative capacity showed 
only minor changes.  
 
The article entitled “Effect of docosahexaenoic acid and eicosapentaenoic acid 
supplementation on oxidative stress levels during pregnancy” analyzes the oxidative 
stress levels in a subgroup of the NUHEAL subjects, who received daily supplementation 
with or without fish-oil. The urinary excretion of 8-hydroxy-2′-deoxyguanosine (8-OHdG), a 
marker of oxidative DNA damage and of malondialdehyde (MDA), a marker of lipid 
peroxidation was estimated at 3 time points. In both groups the urinary MDA excretion 
remained unchanged throughout the study period. In contrast, the urinary 8-OHdG 
excretion was significantly higher at delivery than at week 20 and 30, but no group 
differences were found at the three time points. 
 
On the background of these results it can be concluded that redox markers change over 
time during pregnancy. Under the conditions studied, a daily supplementation of 500 mg 
DHA and 150 mg EPA with appropriate vitamins to pregnant women did not enhance lipid 
peroxidation or oxidative DNA damage. Antioxidant protection seems adequate from the 
data at the time of delivery, but the different TBARS concentrations at week 30 might 
indicate a period of increased oxidative stress, which is overcome by endogenous 
antioxidant response or small compared to other influencing factors. This conclusion is 
also reflected in a wide range of supplementation products available for pregnant women, 
which increasingly contain DHA to close the gap between recommendations and real 
dietary intake. 
 
The article entitled “Dietary Intake of Natural Sources of Docosahexaenoic Acid and 
Folate in Pregnant Women of Three European Cohorts” analyzes the supply with dietary 
folate and DHA in the participants. An optimal intrauterine development and growth as 
well as maternal health require adequate supply of these two nutrients during pregnancy. 
A comparison with the recommendations should identify possible inadequate supplies. 
The analysis was based on data from dietary intake assessed at week 20 and week 30 of 
gestation using a food frequency questionnaire (ffq) focused on the dietary sources of 
folate and DHA. Intake of the nutrients was calculated using the German nutrient data 
base `Bundeslebensmittelschlüssel´ (BLS). Participants whose energy intake was less 
than the estimated basal metabolic rate (BMR) were defined as “under-reporter” and 
excluded from nutritional analysis. While mean macronutrient intakes of our study 
population was found to be quite adequate, our findings clearly show areas of 
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improvement particularly in folate, and to some extent also in DHA supplies. Only 6 % of 
the participating women reached the recommended folate intake during pregnancy 
(600 µg/day), whereas their DHA intakes are in the order of 50-75 % of intakes considered 
desirable. Furthermore, the results agree with other studies, reporting a higher availability 
of fish in Spain than in Hungary and Germany. The main sources for dietary folate were 
vegetables. Other possible dietary DHA sources in addition to the different kinds of fish 
were meat and eggs.  
On the basis of these results and other researches it seems that the core message 
applies not only to the studied cohorts but also to the European women in general. 
Possible ways to improve the supply and to enhance the micronutrient intake is an 
increase in dietary micronutrient density and / or nutrient supplementation. 
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5 Summary (German) 
Diese kumulative Dissertation wurde als eigenständiges Projekt im Rahmen der NUHEAL-
Studie („Nutraceutical for a Healthier Life“, EU FP5, CLK1-CT-1999-00888) durchgeführt. 
Bei dieser Studie handelt es sich um eine prospective, randomisierte, interventionelle 
Studie, die den positiven Einfluss einer Supplementierung mit Fischöl und Folsäure 
während der Schwangerschaft auf verschiedene Parameter des mütterlichen und fetalen 
Organismus untersucht. Für diese Analysen standen Proben von Frauen aus 
Deutschland, Ungarn und Spanien zur Verfügung. Die Probandinnen wurden doppelblind 
in vier verschiedene Gruppen randomisiert und erhielten täglich ein Nahrungsergänzungs-
mittel (Blemil plus, Laboratorios Ordesa, Barcelona, Spanien), welches je nach Gruppen-
Zugehörigkeit modifiziertes Fischöl (500 mg Docosahexaensäure DHA, 150 mg 
Eicosapentaensäure EPA), und/oder 400 µg 5-Methyl-Tetrahydrofolsäure oder ein 
Placebo enthielt. Alle Supplemente enthielten zusätzlich 270 mg Vitamin C sowie 3 mg α-
Tocopherol. Die optimale Versorgung Schwangerer mit langkettigen mehrfach 
ungesättigten Fettsäuren ist von großer Bedeutung für die fetale Entwicklung und 
allgemein anerkannt. So erhöht eine Fischöl-Supplementierung während der 
Schwangerschaft die DHA-Werte im Blut. Auf der anderen Seite sind die LCPUFAs 
jedoch anfällig für Peroxidationsreaktionen und benötigen ausreichenden antioxidativen 
Schutz. Die vorliegende Arbeit analysiert in 3 Artikeln den Effekt einer Supplementierung 
mit Fischöl und/oder Folat auf die Biomarker des Redoxsystems im Verlauf der 
Schwangerschaft sowie die Versorgung der Probandinnen mit Folat und DHA aus der 
Nahrung, um mögliche Defizite in der Versorgung dieser speziellen Bevölkerungsgruppe 
zu identifizieren. 
 
Der Artikel “Influence of fish oil or folate supplementation on the time course of plasma 
redox markers during pregnancy” untersucht die Effekte der Supplementierung mit Fischöl 
und/oder 5-MTHF in der 2. Schwangerschaftshälfte auf den mütterlichen Plasma-
Redoxstatus. Da der Redoxstatus nicht durch einen einzelnen analytischen Parameter 
bewertet werden kann, wurde ein weites Spektrum an Redoxmarkern an 3 verschiedenen 
Zeitpunkten (w20, w30, Geburt) untersucht: α-Tocopherol, freie Thiol-Gruppen, 
Harnsäure, die antioxidative Kapazität (TEAC) sowie die Thiobarbitursäure-reaktive 
Substanzen (TBARS). Die untersuchten Antioxidantien zeigten keinen signifikanten 
Unterschied zwischen den 4 Supplementierungsgruppen. Im Gegensatz dazu gab es in 
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Woche 30 signifikant höhere TBARS Werte in der Fischölgruppe im Vergleich zur Folat- 
und Kontrollgruppe. Bis zum Ende der Schwangerschaft stiegen die TBARS Werte in 
allen Gruppen an, wobei es zum Zeitpunkt der Geburt keinen signifikanten 
Gruppenunterschied mehr gab. Die Plasmakonzentrationen an Retinol und freien Thiol-
Gruppen fielen mit fortschreitender Schwangerschaft ab, während die Harnsäurewerte 
anstiegen. Die ß-Carotin Werte und die antioxidative Kapazität zeigten nur minimale 
Veränderungen im Verlauf der Schwangerschaft und keine Gruppenunterschiede.  
 
Der Artikel mit dem Titel “Effect of docosahexaenoic acid and eicosapentaenoic acid 
supplementation on oxidative stress levels during pregnancy” analysiert die oxidativen 
Stresslevel in einer Subgruppe der NUHEAL Probanden, welche eine Supplementierung 
mit und ohne Fischöl erhalten haben. Zur Beurteilung der Stresslevel wurde die 
Ausscheidung von 8-Hydroxy-2′-deoxyguanosin (8-OhdG), einem Marker für oxidative 
DNA Schädigung und von Malondialdehyd (MDA), einem Marker für Lipidperoxidation, im 
Urin an 3 verschiedenen Zeitpunkten bestimmt. Während des Untersuchungszeitraums 
war die MDA Ausscheidung in beiden Gruppen unverändert. Die Ausscheidung von 8-
OhdG war jedoch zum Zeitpunkt der Geburt signifikant höher im Vergleich zu den beiden 
anderen Zeitpunkten (w20, w30). Signifikante Unterschiede zwischen den beiden 
Gruppen konnten an keinem der 3 Untersuchungszeitpunkte gefunden werden.  
Zusammenfassend kann man feststellen, dass sich die untersuchten Redoxmarker im 
Verlauf der Schwangerschaft verändern und dass der antioxidative Schutz zum Zeitpunkt 
der Geburt als ausreichend eingestuft werden kann. Unter den angegeben 
Studienbedingungen, Supplementierung schwangerer Frauen mit 500 mg DHA, 150 mg 
EPA und entsprechender Vitamingabe, wurde kein Anstieg der Lipidperoxidation oder 
oxidativer DNA Schäden beobachtet. Die unterschiedlichen TBARS Konzentrationen in 
der Woche 30 deuten möglicherweise auf einen Zeitraum mit erhöhtem oxidativen Stress 
hin, der jedoch durch endogene Antioxidantien ausgeglichen werden kann oder im 
Vergleich zu anderen Einflussfaktoren eine unerhebliche Rolle spielt.  
Diese Schlussfolgerung spiegelt sich auch in der Produktpalette der Nahrungs-
ergänzungsmittel für Schwangere wieder, welche zunehmend DHA enthalten, um die 
Lücke zwischen der tatsächlichen Aufnahme und den Empfehlungen für Schwangere zu 
schließen. 
 
Der Artikel mit dem Titel “Dietary Intake of Natural Sources of Docosahexaenoic Acid and 
Folate in Pregnant Women of Three European Cohorts” analysiert die Versorgung der 
NUHEAL-Probandinnen mit Folat und DHA aus der Nahrung. Ein Vergleich mit den 
Empfehlungen soll eine mögliche unzureichende Versorgung aufzeigen. Die Analyse 
Summary (German)  49 
 
basiert auf Daten die mit Hilfe eines auf Folat und DHA fokussierten Verzehrshäufigkeits-
Fragebogens in Woche 20 und 30 erfasst wurden. Die Nährstoffaufnahme wurde mit Hilfe 
der deutschen Nährstoffdatenbank `Bundeslebensmittelschlüssel´ (BLS) berechnet. 
Probandinnen, deren Gesamtenergieaufnahme pro Tag unter ihrem berechneten 
Grundumsatz (BMR) lag, wurden von der Auswertung ausgeschlossen.  
Während die Zufuhr an Makronährstoffen adäquat war, zeigen die Auswertungen 
eindeutige Mängel in der Versorgung mit Folsäure und zu einem gewissen Teil auch in 
der DHA-Aufnahme. Nur 6 % der Probanden erreichten die während der Schwangerschaft 
(600 µg / d) empfohlene Folsäurezufuhr, wohingegen die DHA-Aufnahme im Bereich von 
50-75 % der wünschenswerten Zufuhr lag. Des Weiteren stimmen die Ergebnisse mit 
denen anderer Studien hinsichtlich eines höheren Fischverzehrs in Spanien im Vergleich 
zu Deutschland und Ungarn überein. Als potentielle andere DHA Quellen neben Fisch 
wurden Fleisch und Eier identifiziert. Die Hauptquelle für Nahrungsfolat ist in allen 
Kohorten Gemüse gewesen.  
 
Die Ergebnisse dieser Ernährungserhebung und anderer Studien lassen die Schluss-
folgerung zu, dass die Kernaussage bzgl. der defizitären Versorgung, insbesondere mit 
Folsäure, nicht nur die untersuchten Kohorten betrifft, sondern sich auch auf die 
Europäischen Frauen im Allgemeinen ausweiten lässt. Möglichkeiten, die Zufuhr der 
Mikronährstoffe zu verbessern und damit diesem Trend entgegen zu wirken, wäre ein 
Anstieg der Mikronährstoffdichte in der Nahrung und/oder eine Nährstoffsupplementierung 
der Frauen sowie auch weiterhin eine offensive Aufklärung durch Ärzte und anderes 
medizinisches Personal. 
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6.1 Tables and Figures of the Introduction 
Table 1 Comparison of recommended daily energy and nutrient intakes of adult and pregnant 
women. 
Energy / Nutrients Adult women Pregnancy 
Energy 19-50 y + 340 kcal/d 2nd trimester 
  + 450 kcal/d 3nd trimester 
Protein (g)1 46 71 
DHA (mg)2 220 300 
Vitamin C (mg)1 75 85 
Thiamin (mg)1 1.1 1.4 
Riboflavin (mg)1 1.1 1.4 
Niacin (ng)1 14 18 
Vitamin B6 (mg)1 1.3 1.9 
Folate (µg)1 40 600 
Vitamin B12 (µg)1 2.4 2.6 
Pantothenate (mg)2 5 6 
Biotin (µg)2 30 30 
Vitamin A (µg)1 30 30 
Vitamin D (µg)2 5 5 
Vitamin E (mg)1 15 15 
Vitamin K (µg)2 90 90 
Calcium (mg)2 1000 1000 
Phosphorus (mg)2 700 700 
Magnesium (mg)1 310 350 
Iron (mg)1 18 27 
Zinc (mg)1 8 11 
Iodine (µg)1 150 220 
Selenium (µg)1 55 60 
Fluoride (mg)2 3 3 
1Recommend Dietary Allowance (RDA), average daily dietary intake level that is sufficient to 
meet the nutrient requirements of almost all (97-98%) individuals in a life stage and gender 
group based on Estimated Average Requirements (EAR). 
2Adequate Intake (AI), the value used instead of RDA, if adequate scientific evidence is not 
available to calculate EAR.(1) 
 




Figure 2 Process of DHA accretion in the fetal / infant brain and retina. 




Oxidative stress Oxidative stress 
↓ ↓ 
lipid peroxidation cell damage 
↓ ↓ 
cell damage secondary increased lipid peroxidation    
of damaged cells 
Figure 3 Different sequences of reaction initiated by oxidative stress.  
(according to Halliwell and Chirico (34)). 
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6.2 Chemicals and Equipment 
Table 2 List of chemicals used for the several laboratory analyses. 
Chemicals Source Quality 
TBARS 
  
ortho-phosphoric acid Merck, Darmstadt 85%, extra pure 
2-thiobarbituric acid Fluka, CH-Buchs purum >98% 
1,1,3,3-Tetraethoxy-propane Sigma, approx. 97% 
Sulphoric acid Merck, Darmstadt 98% 
trizma base SIGMA,  reagent grade 
Methanol Merck, Darmstadt LiChrosolv gradient grade 
NaOH Merck, Darmstadt 1N 
Potassium dihydrogen phosphate Merck, Darmstadt GR for analysis 
Potassium hydroxide pellets Merck, Darmstadt GR for analysis 
Water Braun, Melsungen ad injectabilia 
Thiol-groups 
  
DTNB 5,5'-Dithiobis(2-nitrobenzoic acid) SIGMA 99%, per analysis 
Di-sodium hydrogen phosphate dihydrate MERCK, Darmstadt GR for analysis 
Potassium dihydrogen phosphate Merck, Darmstadt GR for analysis 
Sodium chlorid Fluka, CH-Buchs  
L-Cysteine Aldrich, Steinheim 97% 
Water Braun, Melsungen ad injectabilia 
TEAC 
  
Potassium dihydrogen phosphate Merck, Darmstadt GR for analysis 
Di-sodium hydrogen phosphate dihydrate Merck, Darmstadt GR for analysis 
Sodium chlorid Fluka, CH-Buchs  
6-Hydroxy-2,5,7,8-tetramethylchroman-2-
carboxylic acid SIGMA , Steinheim 97% 
2,2'-Azinobis(3-ethylbenzo-thiazoline-6-
sulfonic acid) diammonium salt SIGMA , Steinheim ~ 98% 
Myoglobine equine SERVA, Heidelberg lyophile, research grade 
Hydrogen peroxide Merck, Darmstadt 30%, stabalised for 
synthesis Water Braun, Melsungen ad injectabilia 
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Table 3 List of the equipment used for the laboratory analyses. 
Equipment Source 
Analytical balance, R-200 D Sartorius, Göttingen 
Centrifuge, Universal 30 F Hettrich, Tuttlingen 
Magnet-mover M33001K Heidolph 
Peristaltic Pump, Variopex LKB 
Photometer, anthos hat III Anthos Labtech Instr., Salzburg 
Pipette 10µl, 100µl Abimed, Langenfeld 
Pipette 10-100µl, 50-250µl, 200-1000µl, 500-2500 µl Eppendorf, Wesseling-Berzdorf 
Pipette 10-100 µl, 100-1000µl (Transferpette) Brand, Wertheim 
Pipette 5ml Brand, Wertheim 
Ultrasonic bath, Sonorex Super Badelin, Berlin 
UV-visible Spectrophotometer, CARY 1E VARIAN 
Vortexter, VF 2 IKA, Heitersheim 
Waterbath GFL, Burgwedel 
HPLC 
 
Autosampler, AS-4000 Merck-Hitachi, Darmstadt 
Intelligent pump, L-6200 Merck-Hitachi, Darmstadt 
Fluorescence spectrophotometer, F-1050 Merck-Hitachi, Darmstadt 
Column, R10 LiChrocart 250-4  Merck-Hitachi, Darmstadt 
Column thermostat Gynkotek, Germering 
Software 
 
Microsoft Office Excel 2003 Microsoft GmbH, Unterschleißheim 
Microsoft Office Power Point 2003 Microsoft GmbH, Unterschleißheim 
Microsoft Office Word 2003 Microsoft GmbH, Unterschleißheim 
SPSS, Version 12.0 SPSS GmbH, Software 
Reference Manager 10 ISI Research soft, St. Jones, USA 
EZChrom Elite Client, Version 2.61 Scientific Software, CA, USA 
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Table 4 List for consumables 
Consumables Source 
Brown glass bottle G1, G4 CS-Chromatographie Service, Langerwehe 
Micro inlay G30/5 CS-Chromatographie Service, Langerwehe 
Pipette tip CP100, CP250, CP1000 Gilson, Villiers-le-Bel, France 
Pipette tip 50-1000 µl Eppendorf, Hamburg 
Pipette tip 10-100 µl, 100-1000 µl Greiner bio-one, Frickenhausen 
Screw cap G8-L, G13 CS-Chromatographie Service, Langerwehe 
Sealing disc G13 CS-Chromatographie Service, Langerwehe 
Silicone-PTFE septum, slitted Merck, Darmstadt 
Micro plate, 96-wells BD Falcon, Heidelberg 
UV cuvette semi micro 12.5 x 12.5 45 mm Brand, Wertheim 










 n Mean CV (%)  n Mean CV (%) 
Triglycerides (mg/dl) 
     Level 1 



















Total cholesterol (mg/dl) 
     Level 1 



















Uric acid (mg/dl) 
     Human serum 
     Precinorm U 





















Total protein (g/dl) 
     Human serum 
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Figure 4 HPLC system for the measurement of TBARS plasma concentrations. 
 1 -  autosampler 4  -  fluoreszenz detector 
2 -  column heater  5  -  computer with EZ-chrom Elite  





Figure 5 Equipment used for the TEAC measurement. 
1 - water bath  3 - UV-VIS Spectrophotometer 
2 - peristaltic pump 4 - computer 
 
 
Attachment       57 
 
6.3 Study Questionnaires 
 
 Health and lifestyle questionnaire - week 20 (2 pages) 
 Health and lifestyle questionnaire - week 30 (1 page) 
 Health and lifestyle questionnaire - delivery (2 pages) 




   




Health and lifestyle questionnaire – week 30 
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Food frequency questionnaire in German language (cont. 3) 
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Food frequency questionnaire in German language (cont. 4) 
66 
 
Food frequency questionnaire in German language (cont. 5) 
67 
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